- Home
- JVA vs AWH Comparison
JVA vs AWH Comparison
Compare JVA & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- AWH
- Stock Information
- Founded
- JVA 1971
- AWH 1993
- Country
- JVA United States
- AWH United States
- Employees
- JVA N/A
- AWH N/A
- Industry
- JVA Packaged Foods
- AWH Medical/Dental Instruments
- Sector
- JVA Consumer Staples
- AWH Health Care
- Exchange
- JVA Nasdaq
- AWH Nasdaq
- Market Cap
- JVA 14.7M
- AWH 13.5M
- IPO Year
- JVA 2005
- AWH N/A
- Fundamental
- Price
- JVA $3.04
- AWH $0.82
- Analyst Decision
- JVA
- AWH Buy
- Analyst Count
- JVA 0
- AWH 2
- Target Price
- JVA N/A
- AWH $4.40
- AVG Volume (30 Days)
- JVA 173.3K
- AWH 68.8K
- Earning Date
- JVA 10-11-2024
- AWH 11-11-2024
- Dividend Yield
- JVA N/A
- AWH N/A
- EPS Growth
- JVA N/A
- AWH N/A
- EPS
- JVA 0.20
- AWH N/A
- Revenue
- JVA $76,111,698.00
- AWH $8,923,000.00
- Revenue This Year
- JVA N/A
- AWH $15.59
- Revenue Next Year
- JVA N/A
- AWH $108.47
- P/E Ratio
- JVA $15.39
- AWH N/A
- Revenue Growth
- JVA 17.27
- AWH N/A
- 52 Week Low
- JVA $0.67
- AWH $0.74
- 52 Week High
- JVA $3.88
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- JVA 55.83
- AWH 41.90
- Support Level
- JVA $3.00
- AWH $0.74
- Resistance Level
- JVA $3.74
- AWH $0.89
- Average True Range (ATR)
- JVA 0.32
- AWH 0.06
- MACD
- JVA -0.04
- AWH 0.02
- Stochastic Oscillator
- JVA 17.48
- AWH 56.11
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.